Keywords
HCMV, Abortion, IgG, First trimester, Socioeconomic, El-Damazin, Sudan.
HCMV, Abortion, IgG, First trimester, Socioeconomic, El-Damazin, Sudan.
Cytomegalovirus (CMV) is the most ubiquitous member of the herpes virus family. Human cytomegalovirus (HCMV) is the most common cause of congenital malformation resulting from viral intrauterine infection in developed countries1. CMV infects a high percentage of individuals during their life and after recovery of disease it hides in leukocytes. Although this virus is not considered as hazardous to health, in pregnant women it is a major factor that threatens the health of neonates2. Primary CMV infection occurs in 0.15%–2.00% of all pregnancies and may be transmitted to the fetus in 40% of cases3.
Seroprevalence of HCMV in adults ranges from 55% in developed countries to as high as over 90% in developing countries like China4. In Sudan, age is significantly associated with CMV IgM detection, and history of miscarriage was associated with CMV IgG positive women5. Additionally in Sudan, a study conducted in 2013 by Elamin and Omer at Khartoum Teaching Hospital reported the seroprevalence rate among pregnant women with recurrent abortion as 55.3% and 3.2% for HCMV IgG and IgM antibodies, respectively6. Another recent study in Sudan conducted at Omdurman Maternity Hospital reported a sero-frequency rate of HCMV among pregnant women as 74.4% for CMV IgG and 14.4% for HCMV IgM7.
HCMV can produce maternal infection and exhibits a high tropism for cervical mucosa and is considered as the most implicated virus in recurrent spontaneous abortion (RSA)8. Many pregnant women in Blue Nile State, Sudan, have suffered from recurrent pregnancy loss, and currently there is no available data concerning the prevalence of HCMV in Blue Nile state; therefore, this study aimed to determine HCMV antibodies (IgG and IgM) among pregnant women, who had undergone abortion(s) in this state.
This was a descriptive cross-sectional hospital-based study aimed to detect the seroprevalence of CMV among pregnant women, who had undergone RSA, attending El-Damazin Hospital for Obstetrics and Gynecology in Blue Nile State, Sudan, between March 2017 and February 2019.
Permission to carry out the study was obtained from the College of Graduate Studies, Faculty of Medical Laboratory Sciences, University of Gezira and Ministry of Health, Blue Nile State, Sudan. All women examined were informed about the purpose of the study before collection of the specimens and written consent for participation was taken.
A total of 270 blood samples, taken for the purpose of this study, were collected under aseptic conditions from the participants and sera were separated in sterile containers and stored at -20°C until tested. The inclusion criterion were all pregnant women attending El-Damazin Hospital for Obstetrics and Gynecology, Sudan to undergo an abortion.
Sample size was calculated using the following formula9:
Demographic and clinical data were collected directly from each woman into a predesigned questionnaire (Extended data), including personal information (age, education (no education = illiterate), occupation, socioeconomic status (determined using household income: low, <US$57 per month; moderate, US$57–200 per month; high, >US$200 per month), nationality, number of abortions, duration of pregnancy) and laboratory data.
The laboratory work was carried out in the Regional Public Health Laboratory and Sudanese Chinese Friendship Hospital in El-Damazin using Stat Fax microplate reader (Model: 3200) and Stat Fax washer (Model: 2600) and commercially available ELISA kits (BIOS Microwell Diagnostic System, Chemux Bioscience, Inc., USA for CMV IgM, Lot No: 18-D-055; Fortress Diagnostics Ltd, UK for CMV IgG Lot No: CG-1807-1). Positive and negative results for IgG and IgM were recorded according to calculated cut-off values. For CMV IgG, the cut-off value was obtained by subtracting the blank absorbance from the mean absorbance of calibrator 2.
For CMV IgM the cut-off value was obtained by multiplying the optical density (OD) of the calibrator by factor (F) printed on label of calibrator. CMV IgM index for each sample obtained by dividing OD of sample over the cut- off.
A total of 270 women were enrolled in the study. The majority of the women were aged between 26 and 40 years. Low socioeconomic status was recorded in 84.8% (229/270) of participants, and illiteracy and women obtaining primary education was observed in 80% of participants. Most women were observed to be in the first trimester of pregnancy (85.5%; 231/270) (Table 1). In total, 27.8% (75/270) of the women had a history for 1-7 abortions, while 72.2% (195/270) had no history.
The seroprevalence of HCMV IgG and IgM among the 270 women was 74.8% (202/270) and 13.3% (36/270), respectively (Figure 1).
HCMV IgG detection was significantly correlated to socioeconomic status and gestation stage, but was not correlated to age group and education level (Table 2).
CMV is globally distributed, with 40–100% of the global population positive for CMV antibodies10,11, particularly among low economic individuals12. In Sudan, there are only a few published data (Western and Central Sudan, and Khartoum) concerning epidemiology of HCMV among pregnant women. In our study area, which it located in the South of Sudan, there are no findings about the seroprevalence of HCMV in pregnant women who have had abortions.
The relationship between seroprevalence of HCMV and socioeconomic and education level among the present study population is significant, which may explain poor health status and susceptibility to certain diseases. Numerous studies have evaluated socioeconomic and education level for seroprevalence of HCMV, and most of these studies confirm the strong association between the socioeconomic disparities and high seropositivity13–17
HCMV IgG level in this study was significantly correlated to abortion in the 1st trimester gestation, which has also been shown by other studies1,18. HCMV infection is considered a significant public health problem because it can cause disease in those with weakened immune systems, which has been confirmed by a study in Sudan in which a high frequency (98.3%)of seroprevalence of HCMV among pregnant women was reported19.
In the present study, the sero-prevalence of HCMV among the participants was 74.8% for IgG and 13.3% for IgM; these findings are in total agreement with another study in Sudan among pregnant women7, but is in contrast to other study in Iran in which the frequency for HCMV IgG and IgM was 14.28% and 28.25%, respectively20. Larger and smaller frequencies of HCMV IgG level have also been reported in Egypt21 and Iran22, respectively. The IgM level found in this study is similar to findings reported in Poland (13%) by Fowler and Boppana23, and similar results were obtained by other authors in Iraq24 and India25. Higher results have been reported in Egypt (32.6%) for HCMV IgM18, and lower results have been reported in Turkey26 and Korea27 (1% and 1.7%, respectively). Many factors may contribute to HCMV transmission and prevalence, such as socioeconomic and lifestyle factors, and it should be notes that most immunocompetent carriers of HCMV remain asymptomatic28
In this study, 11.9% of the study population revealed primary infection with HCMV, i.e. positive results for both IgG and IgM. This frequency is larger than that recorded previously in a hospital in Khartoum29.
Seroprevalence of HCMV in Blue Nile State, Sudan, among pregnant women who had undergone abortion(s) was 74.8% for IgG and 13.3% for IgM. HCMV prevalence in pregnant women -was most prevalent for women in the first trimester- with low economic status.
Figshare: HCMV seroprevalence, Blue Nile State, Sudan, https://doi.org/10.6084/m9.figshare.9895715.v130
This project contains the following underlying data:
Figshare: HCMV seroprevalence, Blue Nile State, Sudan, https://doi.org/10.6084/m9.figshare.9895715.v130
This project contains the following extended data:
Data are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication).
Views | Downloads | |
---|---|---|
F1000Research | - | - |
PubMed Central
Data from PMC are received and updated monthly.
|
- | - |
Is the work clearly and accurately presented and does it cite the current literature?
No
Is the study design appropriate and is the work technically sound?
No
Are sufficient details of methods and analysis provided to allow replication by others?
No
If applicable, is the statistical analysis and its interpretation appropriate?
Partly
Are all the source data underlying the results available to ensure full reproducibility?
Partly
Are the conclusions drawn adequately supported by the results?
No
References
1. Leruez-Ville M, Foulon I, Pass R, Ville Y: Cytomegalovirus infection during pregnancy: state of the science.Am J Obstet Gynecol. 223 (3): 330-349 PubMed Abstract | Publisher Full TextCompeting Interests: No competing interests were disclosed.
Reviewer Expertise: Microbiology, Virology
Is the work clearly and accurately presented and does it cite the current literature?
No
Is the study design appropriate and is the work technically sound?
No
Are sufficient details of methods and analysis provided to allow replication by others?
No
If applicable, is the statistical analysis and its interpretation appropriate?
Partly
Are all the source data underlying the results available to ensure full reproducibility?
No
Are the conclusions drawn adequately supported by the results?
No
References
1. Balegamire SJ, Renaud C, Mâsse B, Zinszer K, et al.: Frequency, timing and risk factors for primary maternal cytomegalovirus infection during pregnancy in Quebec.PLoS One. 2021; 16 (6): e0252309 PubMed Abstract | Publisher Full TextCompeting Interests: No competing interests were disclosed.
Reviewer Expertise: Microbiology, General Virology, Molecular Epidemiology
Alongside their report, reviewers assign a status to the article:
Invited Reviewers | ||
---|---|---|
1 | 2 | |
Version 1 10 Oct 19 |
read | read |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Already registered? Sign in
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)